224 related articles for article (PubMed ID: 6429048)
1. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
Siber GR; Ambrosino DM; McIver J; Ervin TJ; Schiffman G; Sallan S; Grady GF
Infect Immun; 1984 Jul; 45(1):248-54. PubMed ID: 6429048
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
3. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
4. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H
Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.
Myerowitz RL; Gordon RE; Robbins JB
Infect Immun; 1973 Dec; 8(6):896-900. PubMed ID: 4150383
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
Ambrosino D; Schreiber JR; Daum RS; Siber GR
Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
[TBL] [Abstract][Full Text] [Related]
7. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
8. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
9. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine.
Lee CJ
Mol Immunol; 1987 Oct; 24(10):1005-19. PubMed ID: 3119993
[TBL] [Abstract][Full Text] [Related]
10. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides.
Pandey JP; Fudenberg HH; Virella G; Kyong CU; Loadholt CB; Galbraith RM; Gotschlich EC; Parke JC
Lancet; 1979 Jan; 1(8109):190-2. PubMed ID: 84209
[TBL] [Abstract][Full Text] [Related]
11. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
13. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
14. Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6.
Ambrosino DM; Delaney NR; Shamberger RC
J Immunol; 1990 Feb; 144(4):1221-6. PubMed ID: 2105993
[TBL] [Abstract][Full Text] [Related]
15. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.
Letson GW; Santosham M; Reid R; Priehs C; Burns B; Jahnke A; Gahagan S; Nienstadt L; Johnson C; Smith D
Pediatr Infect Dis J; 1988 Nov; 7(11):747-52. PubMed ID: 3266005
[TBL] [Abstract][Full Text] [Related]
16. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
17. Passive immunization for the prevention of otitis media.
Englund JA; Glezen WP
Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
Käyhty H; Jousimies-Somer H; Peltola H; Mäketä PH
J Infect Dis; 1981 Jan; 143(1):32-41. PubMed ID: 6783703
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
Santosham M; Reid R; Ambrosino DM; Wolff MC; Almeido-Hill J; Priehs C; Aspery KM; Garrett S; Croll L; Foster S
N Engl J Med; 1987 Oct; 317(15):923-9. PubMed ID: 2442610
[TBL] [Abstract][Full Text] [Related]
20. Detection of Neisseria meningitidis group A, Haemophilus influenzae type b, and Streptococcus pneumoniae antigens in cerebrospinal fluid specimens by antigen capture enzyme-linked immunosorbent assays.
Sippel JE; Prato CM; Girgis NI; Edwards EA
J Clin Microbiol; 1984 Aug; 20(2):259-65. PubMed ID: 6436299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
